{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:24:32Z","timestamp":1787027072433,"version":"build-2736575974"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:00:00Z","timestamp":1663027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    In sickle cell disease (SCD), reduced bioavailability of endothelial NO and cGMP results in reduced expression of phosphodiesterase type 5 (PDE5), thus impairing the penile erection control mechanism and resulting in prolonged penile erection (priapism). In SCD, reduced NO bioavailability is associated with excess plasma hemoglobin due to intravascular hemolysis and increased oxidative stress. Haptoglobin is the plasma protein responsible for reducing plasma hemoglobin levels, but in SCD, haptoglobin levels are reduced, which favors the accumulation of hemoglobin in plasma. Therefore, we aimed to evaluate the effects of haptoglobin treatment on functional and molecular alterations of erectile function, focusing on the contractile and relaxant mechanisms of corpus cavernosum (CC), as well as oxidative stress.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    SCD mice were treated with haptoglobin (400\u00a0mg\/kg, subcutaneous) or vehicle of Monday, Wednesday and Friday for a period of 1 month. Corpus cavernosum strips were dissected free and placed in organ baths. Cumulative concentration-response curves to the acetylcholine, sodium nitroprusside, phenylephrine and KCL, as well as to electrical field stimulation (EFS), were obtained in CC. Protein expressions of eNOS, phosphorylation of eNOS at Ser-1177, nNOS, PDE5, ROCK1, ROCK2, gp91\n                    <jats:sup>phox<\/jats:sup>\n                    , 3-nitrotyrosine, and 4-HNE were measured by western blot in CC.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    Increased CC relaxant responses to acetylcholine, sodium nitroprusside and electrical-field stimulation were reduced by haptoglobin in SCD mice. Reduced CC contractile responses to phenylephrine and KCl were increased by haptoglobin in SCD mice. Haptoglobin prevented downregulated eNOS, p-eNOS (Ser-1177), PDE5, and ROCK2 protein expressions and reduced protein expressions of reactive oxygen species markers, NADPH oxidase subunit gp91phox, 3-nitrotyrosine and 4-HNE in penises from SCD mice. Haptoglobin treatment did not affect ROCK1 and nNOS protein expressions in penises from SCD mice. Basal cGMP production was lower in the SCD group, which was normalized by haptoglobin treatment.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    Treatment with haptoglobin improved erectile function due to up-regulation of eNOS-PDE5 expression and down-regulation of the gp91phox subunit of NADPH oxidase and oxidative\/nitrosative stress in the penises of SCD mice. Treatment with haptoglobin also increased contractile activity due to up-regulation of ROCK2. Therefore, haptoglobin treatment may be an additional strategy to prevent priapism in SCD.\n                  <\/jats:p>","DOI":"10.3389\/fphys.2022.961534","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T11:19:06Z","timestamp":1663067946000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Haptoglobin treatment contributes to regulating nitric oxide signal and reduces oxidative stress in the penis: A preventive treatment for priapism in sickle cell disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Pamela da Silva","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalila Andrade","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiano Beraldi","family":"Calmasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo O.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Brinkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur L.","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Ferreira","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio Henrique","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1046\/j.1464-410x.2002.03022.x","article-title":"Priapism in sickle-cell disease; incidence, risk factors and complications - an international multicentre study","volume":"90","author":"Adeyoju","year":"2002","journal-title":"BJU Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.31744\/einstein_journal\/2020AO5070","article-title":"Prevalence of priapism in individuals with sickle cell disease and implications on male sexual function","volume":"18","author":"Alvaia","year":"2020","journal-title":"Einstein"},{"key":"B3","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1124\/pr.111.004515","article-title":"Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction","volume":"63","author":"Andersson","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0196455","article-title":"Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction","volume":"13","author":"Belcher","year":"2018","journal-title":"PloS One"},{"key":"B5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1182\/blood-2013-04-495887","article-title":"Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease","volume":"123","author":"Belcher","year":"2014","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1016\/j.eururo.2006.10.061","article-title":"Endothelial nitric oxide synthase keeps erection regulatory function balance in the penis","volume":"51","author":"Bivalacqua","year":"2007","journal-title":"Eur. Urol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0068028","article-title":"Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative\/nitrosative stress","volume":"8","author":"Bivalacqua","year":"2013","journal-title":"PloS One"},{"key":"B8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1743-6109.2011.02288.x","article-title":"New insights into the pathophysiology of sickle cell disease\u2010associated priapism","volume":"9","author":"Bivalacqua","year":"2012","journal-title":"J. Sex. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.urology.2010.02.050","article-title":"Attenuated RhoA\/Rho-kinase signaling in penis of transgenic sickle cell mice","volume":"76","author":"Bivalacqua","year":"2010","journal-title":"Urology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.molmed.2020.02.004","article-title":"Haptoglobin therapeutics and compartmentalization of cell-free hemoglobin toxicity","volume":"26","author":"Buehler","year":"2020","journal-title":"Trends Mol. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1073\/pnas.0407183102","article-title":"Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism","volume":"102","author":"Champion","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B12","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.bcmd.2014.12.001","article-title":"Haptoglobin attenuates hemoglobin-induced heme oxygenase-1 in renal proximal tubule cells and kidneys of a mouse model of sickle cell disease.","volume":"54","author":"Chintagari","year":"2015","journal-title":"Blood Cells, Mol. Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/83258","article-title":"Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway","volume":"7","author":"Chitaley","year":"2001","journal-title":"Nat. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0154866","article-title":"Men with sickle cell anemia and priapism exhibit increased hemolytic rate, decreased red blood cell deformability and increased red blood cell aggregate strength","volume":"11","author":"Cita","year":"2016","journal-title":"PloS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ucl.2021.07.003","article-title":"Management of priapism","volume":"48","author":"Ericson","year":"2021","journal-title":"Urologic Clin. N. Am."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jacc.2011.10.900","article-title":"Cardiovascular abnormalities in sickle cell disease","volume":"59","author":"Gladwin","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.niox.2018.04.011","article-title":"Physiological activation and deactivation of soluble guanylate cyclase","volume":"77","author":"Horst","year":"2018","journal-title":"Nitric Oxide"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1182\/blood-2006-08-039438","article-title":"Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability","volume":"109","author":"Hsu","year":"2007","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","first-page":"16624","DOI":"10.1073\/pnas.1213790109","article-title":"Cyclic AMP-dependent phosphorylation of neuronal nitric oxide synthase mediates penile erection","volume":"109","author":"Hurt","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1182\/blood-2005-06-2373","article-title":"Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease","volume":"107","author":"Kato","year":"2006","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1743-6109.2011.02287.x","article-title":"Priapism in sickle\u2010cell disease: A hematologist's perspective","volume":"9","author":"Kato","year":"2012","journal-title":"J. Sex. Med."},{"key":"B22","first-page":"916","article-title":"Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle","volume":"262","author":"Kowaluk","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B23","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.juro.2012.08.198","article-title":"Molecular analysis of erection regulatory factors in sickle cell disease associated priapism in the human penis","volume":"189","author":"Lagoda","year":"2013","journal-title":"J. Urology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1096\/fj.13-228817","article-title":"Sustained nitric oxide (NO)\u2010releasing compound reverses dysregulated NO signal transduction in priapism","volume":"28","author":"Lagoda","year":"2014","journal-title":"FASEB J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/sj.ijir.3900802","article-title":"Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters","volume":"14","author":"Lin","year":"2002","journal-title":"Int. J. Impot. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/00043426-199911000-00013","article-title":"Prevalence of priapism in children and adolescents with sickle cell anemia","volume":"21","author":"Mantadakis","year":"1999","journal-title":"J. Pediatr. Hematology\/Oncology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2020.107493","article-title":"Pharmacology and perspectives in erectile dysfunction in man","volume":"208","author":"Mitidieri","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"B28","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1182\/blood.v32.5.811.811","article-title":"Brief report: Plasma concentrations of hemopexin, haptoglobin and heme in patients with various hemolytic diseases","volume":"32","author":"Muller-eberhard","year":"1968","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/14728222.2020.1745188","article-title":"Mechanisms underlying priapism in sickle cell disease: Targeting and key innovations on the preclinical landscape","volume":"24","author":"Musicki","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"B30","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/andr.12442","article-title":"Testosterone replacement in transgenic sickle cell mice controls priapic activity and upregulates PDE5 expression and eNOS activity in the penis","volume":"6","author":"Musicki","year":"2018","journal-title":"Andrology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1002\/jcp.30075","article-title":"TSPO ligand FGIN\u20101\u201027 controls priapism in sickle cell mice via endogenous testosterone production","volume":"236","author":"Musicki","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1111\/j.1743-6109.2012.02798.x","article-title":"Targeting NADPH oxidase decreases oxidative stress in the transgenic sickle cell mouse penis","volume":"9","author":"Musicki","year":"2012","journal-title":"J. Sex. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0014-5793(96)00811-3","article-title":"ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine\/threonine kinase in mice","volume":"392","author":"Nakagawa","year":"1996","journal-title":"FEBS Lett."},{"key":"B34","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1182\/blood-2005-04-1594","article-title":"Hemolysis-associated priapism in sickle cell disease","volume":"106","author":"Nolan","year":"2005","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1124\/jpet.114.220970","article-title":"Beneficial effect of the soluble guanylyl cyclase stimulator BAY 41-2272 on impaired penile erection in db\/db\u2212\/\u2212 type II diabetic and obese mice","volume":"353","author":"Nunes","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1152\/physrev.00029.2006","article-title":"Nitric oxide and peroxynitrite in health and disease","volume":"87","author":"Pacher","year":"2007","journal-title":"Physiol. Rev."},{"key":"B37","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1126\/science.278.5339.876","article-title":"Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease","volume":"278","author":"Pa\u0301szty","year":"1997","journal-title":"Science"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/nm1202-799","article-title":"Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease","volume":"8","author":"Reiter","year":"2002","journal-title":"Nat. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"500","DOI":"10.3389\/fphys.2014.00500","article-title":"The pathophysiology of extracellular hemoglobin associated with enhanced oxidative reactions","volume":"5","author":"Rifkind","year":"2014","journal-title":"Front. Physiol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cardiores.2007.03.030","article-title":"Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells","volume":"75","author":"Selemidis","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.eururo.2013.11.008","article-title":"European Association of Urology guidelines on priapism","volume":"65","author":"Salonia","year":"2014","journal-title":"Eur. Urol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bcmd.2018.07.002","article-title":"Serum haptoglobin and hemopexin levels are depleted in pediatric sickle cell disease patients","volume":"72","author":"Santiago","year":"2018","journal-title":"Blood Cells, Mol. Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1164\/rccm.201510-2058OC","article-title":"Haptoglobin preserves vascular nitric oxide signaling during hemolysis","volume":"193","author":"Schaer","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1182\/blood-2012-11-451229","article-title":"Hemolysis and free hemoglobin revisited: Exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins","volume":"121","author":"Schaer","year":"2013","journal-title":"Blood"},{"key":"B45","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/bjh.14280","article-title":"Sustained treatment of sickle cell mice with haptoglobin increases HO-1 and H-ferritin expression and decreases iron deposition in the kidney without improvement in kidney function","volume":"175","author":"Shi","year":"2016","journal-title":"Br. J. Haematol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e0166291","DOI":"10.1371\/journal.pone.0166291","article-title":"Sympathetic hyperactivity, increased tyrosine hydroxylase and exaggerated corpus cavernosum relaxations associated with oxidative stress plays a major role in the penis dysfunction in townes sickle cell mouse","volume":"11","author":"Silva","year":"","journal-title":"PloS One"},{"key":"B47","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1124\/jpet.116.235473","article-title":"Beneficial effect of the nitric oxide donor compound 3-(1,3-Dioxoisoindolin-2-yl)Benzyl nitrate on dysregulated phosphodiesterase 5, NADPH oxidase, and nitrosative stress in the sickle cell mouse penis: Implication for priapism treatment","volume":"359","author":"Silva","year":"","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B48","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrurol.2014.278","article-title":"Understanding and targeting the Rho kinase pathway in erectile dysfunction","volume":"11","author":"Sopko","year":"2014","journal-title":"Nat. Rev. Urol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1124\/jpet.107.124594","article-title":"Effects of 5-Cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine (BAY 41-2272) on smooth muscle tone, soluble guanylyl cyclase activity, and NADPH oxidase activity\/expression in corpus cavernosum from wild-type, neuronal, and endothelial nitric-oxide synthase null mice","volume":"322","author":"Teixeira","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B50","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41573-018-0003-2","article-title":"Therapeutic strategies for sickle cell disease: Towards a multi-agent approach","volume":"18","author":"Telen","year":"2019","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2022.961534\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T11:19:10Z","timestamp":1663067950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2022.961534\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,13]]},"references-count":50,"alternative-id":["10.3389\/fphys.2022.961534"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2022.961534","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,13]]},"article-number":"961534"}}